Immuneering Corp - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Name: Immuneering Corp - Ordinary Shares Class A: Is Infosys Ltd. worth buying?
Item: Immuneering Corp - Ordinary Shares Class A
Rating: 1.54983325
Author: Trendlyne DVM scores

about

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

5.61 0.03 (0.54%)

44.35% Fall from 52W High

998.1K

XNAS Volume

XNAS 20 Oct, 2025 4:12 PM (EDT)

Not Eligible

Expensive Valuation

2.3 / 100

Technically Neutral

59.7 / 100

No estimates available

Immuneering Corp Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Immuneering Corp - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

44.35% Fall from 52W High

SWOT Analysis

Immuneering Corp Ordinary Live Price Chart